Wegovy Tablets vs Wegovy Injection: Which Is Right for You?

Same medicine, two very different routines — how the new daily semaglutide pill compares with the weekly injection on results, side effects and day-to-day practicality.

Part of the Overweight and Obesity Guide.

Until June 2026, choosing Wegovy meant choosing a needle. The MHRA’s approval of Wegovy tablets — a once-daily 25mg oral semaglutide pill — changed that, and it has left many people asking an entirely new question: pill or pen?

The honest answer is that neither is “better” across the board. They contain the same active ingredient and produce similar results, so the right choice depends almost entirely on which routine you can sustain. This guide lays out the differences so you can decide with your prescriber.

One medicine, two formulations

Both products contain semaglutide, a GLP-1 receptor agonist that reduces appetite, increases fullness and slows stomach emptying. The injection delivers it weekly under the skin at doses up to 2.4mg; the tablet delivers it daily by mouth at doses up to 25mg. The oral dose is much higher because only a small fraction of swallowed semaglutide survives the stomach and reaches the bloodstream — the tablet’s SNAC absorption enhancer makes that fraction just large enough to match the injection’s effect.

The differences at a glance

Effectiveness compared

There is no direct head-to-head trial of the two formulations for weight loss, so the fairest comparison is between their pivotal trials — which used similar populations and lifestyle support:

Those numbers are close enough that clinicians treat the formulations as broadly equivalent in effect. One practical nuance: the tablet’s result depends more heavily on taking it correctly. Skipped fasting windows and inconsistent timing blunt absorption in a way that a weekly injection simply cannot suffer from. If you take the tablet properly, the gap all but disappears — in OASIS 4, around a third of fully adherent participants lost 20% or more of their body weight.

The daily routine vs the weekly jab

This is where the two genuinely differ, and where most people find their answer.

The right question isn’t “which is more convenient?” in the abstract — it’s “which will I still be doing properly in month eight?” A morning person with a stable routine may find the tablet effortless. A shift worker with chaotic mornings may do far better injecting once a week.

Side effects compared

Because the active ingredient is identical, the core side effect profile is shared: nausea, diarrhoea, constipation and vomiting are the most common effects of both, concentrated around dose increases and usually settling with time. The class cautions are also identical — neither should be used in pregnancy, with a history of medullary thyroid carcinoma or MEN2, and both carry small risks of gallbladder problems and pancreatitis.

The differences are at the margins:

• Tablet: no injection-site reactions; slightly more upper-digestive complaints (indigestion, burping) reported with oral semaglutide
• Injection: occasional injection-site redness or irritation; no fasting rules, so it interferes less with other oral medicines
• Both: most side effects are mild to moderate, and slower dose escalation is the standard fix when they aren't

The management advice is the same for both formulations — smaller meals, less fat, more fluids during titration. Our guide to managing GLP-1 side effects on Mounjaro covers tactics that apply equally here.

Which one suits you?

Whichever you lean towards, the decision is made with a prescriber — they will weigh your medicines, medical history and preferences before recommending a formulation. And switching later is possible under clinical supervision, so the first choice is not a life sentence.

Both Wegovy formulations are available from Access Doctor following an online consultation reviewed by a GPhC-registered pharmacist independent prescriber, dispensed from our UK pharmacy.